You are here

Cancer diagnostics firm Biolidics lodges prospectus for Catalist IPO


MEDICAL technology firm Biolidics Limited, a cancer diagnostic solutions developer formerly known as Clearbridge Biomedics, lodged a preliminary prospectus on Friday for a planned initial public offering (IPO) on the Singapore Exchange's Catalist board.

Details of the...

Market voices on: